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Methods: Experimental OA was induced by intra-articular injec-
tion of MIA into right hind knee of male Wistar rats. Mechanical
hyperalgesia and knee joint pain were measured by von Frey ﬁla-
ment and Incapacitance Tester, respectively. First, we examined
the dose- and the time-dependency of analgesic effect of single
administration of Neurotropin on the pain of MIA-induced OA
rats. To clarify the effects of repetitive dosing on OA pain, Neu-
rotropin at doses of 100 or 200 NU/kg was orally administered to
MIA-induced OA rats from day 7 to day 28. Furthermore, repet-
itive oral administrations of Neurotropin (200 NU/kg), loxoprofen
(2 mg/kg), or meloxicam (2 mg/kg) were carried out from day 7
to day 21, and mechanical hyperalgesia and knee joint pain were
measured at 24 hours after Neurotropin administration. To clarify
the action mechanisms of Neurotropin, antagonists for receptor
of alpha2 noradrenergic, 5-HT2A, or 5-HT3 related with descend-
ing pain inhibitory pathways were intrathecally administered at
45 minutes after Neurotropin treatment, and then mechanical
hyperalgesia was measured at 15 minutes after administration of
antagonists.
Results: MIA at doses of 0.3, 1.0, 3.0 mg/site developed me-
chanical hyperalgesia and knee joint pain in a dose dependent
manner. The single administration of Neurotropin (100, 200, 400
NU/kg) ameliorated mechanical hyperalgesia of OA rats in a dose
dependent manner. This antinociceptive effect of Neurotropin at
a dose of 200 NU/kg was reached to a peak at 1 hour and
disappeared at 24 hour after Neurotropin treatment. However,
the single dose of Neurotropin was not ameliorated knee joint
pain of OA rats. In comparison, repetitive oral administration of
Neurotropin signiﬁcantly ameliorated not only mechanical hyper-
algesia but also knee joint pain of OA rats even at 24 hour
after Neurotropin treatment. Repetitive oral administration of lox-
oprofen or meloxicam was signiﬁcantly ameliorated mechanical
hyperalgesia and knee joint pain as well as Neurotropin treat-
ment. However, repetitive treatment of loxoprofen or meloxicam
induced gastro mucosal injury, but Neurotropin did not. The
inhibitory effect of single dose of Neurotropin on mechanical
hyperalgegia of OA was blocked by intrathecal injection of 30
nmol of yohimbine (alpha2 noradrenaline receptor antagonist),
100 nmol of ketanserin (5-HT2A receptor antagonist), or 30 nmol
of MDL72222 (5-HT3 receptor antagonist).
Conclusions: These results indicate that the analgesic effect
of Neurotropin on chronic pain of MIA-induced OA rats is com-
parable to NSAIDs and Neurotropin is safer than NSAIDs. The
descending pain inhibitory pathway might be involved in the
analgesic effect of Neurotropin on mechanical hyperalgesia of
MIA-induced OA rats.
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Purpose: Pain in osteoarthritis (OA) is exacerbated both by
movement and by weight bearing on the affected joint. To in-
vestigate the occurrence and the time-course of pain related
behaviours in an experimental model of OA, we used the knee
bend, CatWalk (CW) and pin-prick tests, as well the von Frey
and Randall-Selitto tests.
Methods: OA was induced by injection of mono-iodoacetate
(MIA), in the left knee joint of adult male Wistar rats, at doses of
2 or 3 mg/joint. Control animals received a similar injection with
saline. Paw withdrawal thresholds (PWT) to von Frey ﬁlaments
and Randall-Selitto, score of knee-bend test, hind paw-print
intensity (assessed using a CW apparatus and expressed as
total intensity of the ipsilateral paw as a percentage of the total
intensity of both hindpaws) and paw withdrawal latency (PWL)
to pin-prick test were measured before the induction of OA and
on various days for up to 31 days post-injection of MIA, on both
sides.
Results: In every time point studied, PWT values and the hind-
paw load distribution of OA rats were signiﬁcantly smaller than
those observed for the control group (P<0.01 and P<0.05,
respectively), reﬂecting a mechanical allodynia. Similarly, the
knee-bend score for the OA groups showed signiﬁcantly higher
values when compared to the control animals (P<0.05), indica-
tive of the animal’s allodynia and hyperalgesia. No signiﬁcant
difference was observed between the two OA groups in any of
these tests, as well as no signiﬁcant differences were observed
in the Randall-Selitto and pin-prick test between the OA and the
control animals.
Conclusions: We conclude that the catwalk and knee-bend test
are very useful and effective methods for evaluating movement
pain and disability induced by this experimental model of OA
in the rat, and are better predictors of the animal allodynia and
hyperalgesia than the Randall-Selitto and pin-prick tests.
Supported by POCTI/SAU-NEU/60853/2004, FCT, Portugal and
FEDER.
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Purpose: Mitochondria are involved in many cellular processes,
and mitochondrial dysfunctions have been associated with apop-
tosis, aging and a number of pathological conditions, including
osteoarthritis (OA). Mitochondrial proteins are an attractive tar-
get to study the metabolism of chondrocyte and its role in the
cartilage degradation. Using a proteomic approach, we have an-
alyzed the mitochondrial protein changes that are characteristic
of OA chondrocytes, and we have identiﬁed by these means new
OA-related mitochondrial proteins.
Methods: Chondrocytes were obtained from 6 OA patients un-
dergoing joint replacement, and from 6 cartilages from autopsies
without history of joint disease. Mitochondria were isolated by
homogenization and differential centrifugation processes. Differ-
ential expression analysis was carried out using the differential
in-gel electrophoresis technology (DIGE). Brieﬂy, mitochondrial
proteins from control and OA samples were labelled with differ-
ent ﬂuorescent dyes, mixed by pairs and co-resolved by two-
dimensional gel electrophoresis using a pool of all samples as
internal standard. Gel images were acquired with the Typhoon
scanner, and biological variation analysis was performed using
the DeCyder 6.5 software. OA-related proteins were identiﬁed by
matrix-assisted laser desorption/ionization-time of ﬂight (MALDI-
TOF) or MALDI-TOF/TOF mass spectrometry. Extended statistic
and clustering analysis of the data was performed with the EDA
module of DeCyder software. Validation of the results was carried
out by Western blotting and immunoﬂuorescence analyses.
Results: We examined more than 1500 protein spots that were
present in the six different DIGE gels. Both qualitative and quan-
titative changes in protein expression patterns between normal
and OA chondrocyte mitochondria were studied. 36 protein spots
were found to be statistically increased in OA cells compared to
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Abstract 388 – Table 1
Protein ID Ratio T-test Name
Mitochondrial proteins increased in OA THIM 1.61 0.0015 3-ketoacyl-CoA-thiolase
KAD4 1.52 0.014 Adenylate kinase isoenzyme 4, mitochondrial
IMMT 1.50 0.038 Mitochondrial inner membrane protein (mitoﬁlin), isoform 1
TRAP1 1.47 0.041 TNF receptor-associated protein 1 (Hsp75)
SCOT 1.41 0.035 Succinyl-CoA 3-ketoacid coenzyme A transferase 1
NDUV1 1.36 0.029 NADH dehydrogenase (ubiquinone) ﬂavoprotein 1, mitochondrial prec.
NDUS8 1.32 0.031 NADH dehydrogenase (ubiquinone) iron-sulfur prot 8, mit. precursor
Mitochondrial Proteins decreased in OA OPA1 -1.34 0.0038 Dynamin-like 120 kDa protein, mitochondrial
VDAC2 -1.36 0.049 Voltage-dependent anion-selective channel protein 2
HIBCH -1.36 0.049 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial precursor
ECHA -1.4 0.036 Trifunctional enzyme subunit alpha, mitochondrial
IMMT -1.4 0.0066 Mitochondrial inner membrane protein (mitoﬁlin), isoform 2
ODPA -1.5 0.017 Pyruvate dehydrogenase E1 component α sub, mitoch. precursor
SODM -1.5 0.011 Mn Superoxide dismutase
IDHP -1.5 0.0074 Isocitrate dehydrogenase (NADP), mitochondrial precursor
DHSA -1.56 0.007 Succinate dehydrogenase [ubiquinone] ﬂavoprotein subunit
GLSK -1.6 0.007 Glutaminase kidney isoform, mitochondrial precursor
SODM -1.6 0.0024 Mn Superoxide dismutase
IDH3A -1.69 0.015 Isocitrate dehydrogenase [NAD] subunit alpha
IMMT -1.7 0.021 Mitochondrial inner membrane protein (mitoﬁlin), isoform 3
ETFA -1.7 0.038 Electron transfer ﬂavoprotein subunit α, mitochondrial precursor
IDH3A -1.9 0.038 Isocitrate dehydrogenase [NAD] subunit alpha
the pattern of normal chondrocytes (ratio OA:N≥1.3, p<0.05),
including the TNFα-receptor-associated protein (TRAP1) and
two subunits of the mitochondrial respiratory chain complex I.
On the other hand, 60 protein spots were decreased in OA
chondrocytes, including two mitoﬁlin and two superoxide dismu-
tase isoforms. Identiﬁed proteins whose cellular localization was
previously described as mitochondrial are listed in the Table.
Unsupervised Principal Component Analysis and hierarchical
clustering allowed the recognition of OA and control samples
by their protein proﬁles. Validation of the results was performed
for the TNFα-receptor associated protein TRAP1 by immunoﬂu-
orescence, real-time PCR and western blot assays. This protein
was found to be increased speciﬁcally the deep layer of OA
chondrocytes.
Conclusions: This study describes the differences between the
mitochondrial protein proﬁles of normal and OA chondrocytes.
pointing out the mitochondrial alterations that take place in carti-
lage degradation during osteoarthritis.
389
CYTOSKELETAL DISTORTIONS IN HUMAN
OSTEOARTHRITIC CHONDROCYTES REVEALED BY A
DIFFERENTIAL PROTEOME ANALYSIS
S. Lambrecht1, G. Verbruggen2, P. Verdonk2, D. Elewaut2,
D. Deforce1
1Ghent University, Gent, Belgium; 2Ghent University Hospital,
Gent, Belgium
Purpose: A proteome analysis of human articular chondrocytes
was conducted to identify proteins, differentially expressed in
chondrocytes during the progression of osteoarthritis (OA).
Methods: The proteins of 20 samples of human chondrocytes
obtained from the cartilage of human knees (6 from healthy
cartilage (NoNo), 7 from visually intact zones (NoOA) and 7
from visually damaged zones (OAOA) of OA-cartilage from the
same knee joint) were sequentially extracted and subjected to
two-dimensional gel electrophoresis. Protein expression patterns
were subjected to statistical analysis and protein spots of in-
terest were identiﬁed by electrospray ionization tandem mass
spectrometry.
Results: The chondrocytes isolated from visually intact zones of
OA-cartilage showed a different expression pattern for a substan-
tial number of proteins compared to chondrocytes isolated from
healthy controls, hereby conﬁrming the hypothesis that chondro-
cytes undergo phenotypic alterations even before the develop-
ment of visible cartilage damage. Furthermore, new players were
identiﬁed in processes known to be involved in the pathogenesis
of OA such as apoptosis, oxidative stress and metabolic activa-
tion. Of special interest was the detection of cleaved vimentin,
which was upregulated in OAOA samples. The higher abundance
of vimentin cleavage products was conﬁrmed by Western blot.
The possible impact of vimentin cleavage on the chondrocyte’s
cytoskeleton was illustrated by confocal microscopy analysis,
which revealed a distorted vimentin organisation in OA chondro-
cytes. In contrast, F-actin staining did not reveal differences.
Conclusions: All together, this study revealed several differen-
tially expressed proteins in osteoarthritic chondrocytes. Further
validation experiments clearly point to substantial alterations in
the vimentin cytoskeleton in OA-affected human articular chon-
drocytes.
390
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Purpose: In recent years, some studies have been initiated to
disclose the proteome of human chondrocytes and cartilage.
Despite these studies, comprehensive information of the chon-
drocyte proteome remains limited. Especially the membrane and
low-abundance proteome remain largely unknown. This study
aims to dig further in the proteome expressed by human knee
chondrocytes, thereby providing a database for future biomolec-
ular research.
Methods: Chondrocytes isolated from human knee cartilage
samples were cultured in a three-dimensional alginate culture
system. To simplify the protein mixtures, proteins extracted from
chondrocyte cell lysates were fractionated based on hydropho-
bicity and molecular weight. Proteins were digested and the
resulting peptides were separated and identiﬁed by an on-line
2-D nanoLC system coupled to a Qq-TOF mass spectrometer.
Results: Using extensive prefractionation based on the hy-
drophobicity and molecular weight of the proteins, we were able
to identify several membrane proteins, and other low-abundance
